
Opinion|Videos|October 18, 2024
Addressing Unmet Needs in ART
Author(s)Jeffrey Dunn, PharmD, MBA
Jeffrey Dunn, Pharm.D., MBA, discusses how key unmet needs in assisted reproductive technology (ART) programs drive ongoing research and innovation, fostering hope for a future where fertility treatments are more effective, accessible and tailored to individual patient needs.
Advertisement
Episodes in this series

Advertisement
Related to this article

A Centene OB-GYN and an AAFP family physician explain how health plans, primary care and policy can help close rural maternity care gaps.

Nelkarmi gives ALK-positive lung cancer patients a new option after first-line therapy stops working
The FDA granted accelerated approval to GSK's Nelkarmi for previously treated ALK-positive NSCLC, the company's second lung cancer approval this year.

A pooled review of 40 studies tied type 2 diabetes to a 53% higher Alzheimer’s risk, with incidence more than doubling when clinicians made the diagnosis.

Lockton's Sarah Klein says employers are already asking hard questions about PBM transparency, even though many of the new rules have not taken effect.

WIC participation is estimated at only 44% of eligible Medicaid enrollees in 2023, and just 15% of pregnant Medicaid enrollees. Health plans can help close that gap, but only if their referrals are tracked through enrollment.

Heidi Overton ran into opposition from Republican senators concerned about her role in setting White House vaccine policy.

In more than 256,000 adults with prediabetes and obesity, GLP-1s were linked to better blood sugar and heart outcomes than metformin, according to a study presented at the American Heart Association (AHA) Scientific Sessions 2026.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Closing rural maternity care gaps starts close to home, Centene and AAFP leaders say
2
The role of Janus kinase inhibitors
3
Takeda launches Orzeyful, first orexin agonist for narcolepsy type 1
4
Type 2 diabetes associated with 53% higher Alzheimer’s risk, with claims data likely undercounting cases, review shows
5



